J&J Offloads LifeScan To Private Equity Firm For $2.1bn

 
• By Reed Miller
Business decline
J&J's divestment of LifeScan is part of its overall plan to get out of the diabetes device business. • Source: shutterstock.com

More from Deals

More from Business